Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Cornell University · Memorial Sloan Kettering Cancer Center · +35 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
254
total citations
- FWCI
- 94.02
- Percentile
- 100%
- References
- 28
Citations per year
Authors
43- SPSandra P. D’AngeloCorresponding
Cornell University, Memorial Sloan Kettering Cancer Center
- DMDejka M. Araujo
The University of Texas MD Anderson Cancer Center
- ARAlbiruni R. Abdul Razak
Princess Margaret Cancer Centre, University Health Network
- MAMark Agulnik
City of Hope
- SASteven Attia
Mayo Clinic in Florida, WinnMed
Topics & keywords
Topics
Keywords
- Medicine
- Internal medicine
- Cohort
- Synovial sarcoma
- Population
- Sarcoma
- Myxoid liposarcoma
- Surgery
No related works found for this paper.
Funding
- AAmgen
- PPfizer
- GGlaxoSmithKline
- SSanofi
- GSGilead Sciences
- APAlexion Pharmaceuticals
- SUSarcoma UK
- RPRegeneron Pharmaceuticals
- EExelixis
- NCNational Comprehensive Cancer Network
- DPDeciphera Pharmaceuticals
- IIncyte
- ITIterion Therapeutics
- CRCancer Research UK
- NINational Institute for Health and Care Research
- DDaiichi-Sankyo
- APAstellas Pharma
- UCUniversity College London Hospitals NHS Foundation Trust
- SServier
- PPharmaMar
- SSymphogen
- GGenentech
- ESEMD Serono
- MRMedical Research Council
- DSDaiichi Sankyo Europe